Your browser doesn't support javascript.
loading
Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer.
Pal, Sumanta Kumar; Vuong, Winston; Zhang, Wang; Deng, Jiehui; Liu, Xueli; Carmichael, Courtney; Ruel, Nora; Pinnamaneni, Manasvi; Twardowski, Przemyslaw; Lau, Clayton; Yu, Hua; Figlin, Robert A; Agarwal, Neeraj; Jones, Jeremy O.
Afiliação
  • Pal SK; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Vuong W; Department of Cancer Biology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Zhang W; GenScript, Nanjing City, Jiangsu, China.
  • Deng J; Department of Cancer Immunotherapeutics and Tumor Immunology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Liu X; Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Carmichael C; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Ruel N; Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Pinnamaneni M; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Twardowski P; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Lau C; Department of Urology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Yu H; Department of Cancer Immunotherapeutics and Tumor Immunology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Figlin RA; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Agarwal N; Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah.
  • Jones JO; Department of Cancer Biology, City of Hope Comprehensive Cancer Center, Duarte, California. jjones@coh.org.
Mol Cancer Ther ; 14(12): 2896-900, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26450920
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Imidazóis / Indazóis Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Imidazóis / Indazóis Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article